首页 | 本学科首页   官方微博 | 高级检索  
检索        

人催乳素受体拮抗剂G129R-hPRL在乳腺肿瘤治疗中的研究进展
引用本文:顾丽,张君,苏燕.人催乳素受体拮抗剂G129R-hPRL在乳腺肿瘤治疗中的研究进展[J].中国现代应用药学,2011,28(1):30-34.
作者姓名:顾丽  张君  苏燕
作者单位:内蒙古科技大学包头医学院,a.病原生物学教研室,内蒙古 包头 014060;生物化学与分子生物学教研室,内蒙古 包头 014060;生物化学与分子生物学教研室,内蒙古 包头 014060
基金项目:内蒙古自治区自然科学基金项目(200711020913)
摘    要:目的 介绍特异性人催乳素(PRL)受体拮抗剂G129R-hPRL在乳腺肿瘤治疗中的研究进展.方法 查阅近年采国内外相关文献进行总结和归纳,对G129R-hPRL的功能、作用机制、优缺点、改进措施以及在乳腺肿瘤治疗中的应用和今后的发展方向进行综述.结果 G129R-hPRL通过竞争性拮抗内源性PRL的作用进而抑制乳腺癌细...

关 键 词:催乳素  催乳素受体拮抗剂  G129R-hPRL  乳腺肿瘤
收稿时间:4/6/2010 12:00:00 AM

Advances in the Research of Human Prolactin Receptor Antagonists G129R-hPRL in Breast Cancer Therapy
GU Li,ZHANG Jun and SU Yan.Advances in the Research of Human Prolactin Receptor Antagonists G129R-hPRL in Breast Cancer Therapy[J].The Chinese Journal of Modern Applied Pharmacy,2011,28(1):30-34.
Authors:GU Li  ZHANG Jun and SU Yan
Institution:Baotou Medical College, Inner Mongolia University of Science and Technology, a.Department of Pathogenic Organism, Baotou 014060, China;Department of Biochemistry Andmolecular Biology, Baotou 014060, China;Department of Biochemistry Andmolecular Biology, Baotou 014060, China
Abstract:OBJECTIVE To introduce the progress of specific human prolactin receptor antagonist G129R-hPRL in breast cancer therapy research. METHODS Review the function, mechanism, advantages and disadvantages, improvements, the application and the prospect of the prolactin receptor antagonist G129R-hPRL in therapy of breast tumor through searching and summarizing relevant literatures. RESULTS G129R-hPRL can inhibit proliferation, mediate apoptosis of breast cancer cell and play the role of anti-breast cancer by competitively antagonize endogenous prolactin. G129R-hPRL-based multi-functional fusion protein, as well as combination G129R-hPRL with other anti-tumor component also shows a stronger tumor suppressor effect. CONCLUSION G129R-hPRL is expected to be an ideal drug in treatment and prevention of breast cancer.
Keywords:prolactin  prolactin receptor antagonist  G129R-hPRL  breast tumor
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《中国现代应用药学》浏览原始摘要信息
点击此处可从《中国现代应用药学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号